Standout Papers

The Economic Burden of Adults with Major Depressive Disorder in the United States (2019) 2023 2026 202455
  1. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019) (2023)
    RN, A.S. Chitnis et al. Advances in Therapy

Immediate Impact

36 standout
Sub-graph 1 of 15

Citing Papers

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
2 intermediate papers

Works of Ellison Suthoff being referenced

Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial
2015
Impact of Early Versus Late Systemic Lupus Erythematosus Diagnosis on Clinical and Economic Outcomes
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Ellison Suthoff 121 76 41 71 34 425
Jörg Bätzing 26 46 46 30 29 477
Arindam Pande 48 47 17 47 56 389
Feng Tian 56 35 7 24 36 490
Jacques Massol 99 27 20 36 39 407
Fatih Kayhan 48 38 24 23 28 473
Xinyu Liu 25 59 61 17 49 496
Andrew Crawford 35 32 20 41 19 403
Jinjing Tan 22 38 36 15 26 492
Carole Dembek 135 26 32 28 42 506
Yuanyuan Qu 30 19 18 15 41 466

All Works

Loading papers...

Rankless by CCL
2026